MD1474G2 - Method of treatment of the puerperal endometritis - Google Patents

Method of treatment of the puerperal endometritis

Info

Publication number
MD1474G2
MD1474G2 MD99-0076A MD990076A MD1474G2 MD 1474 G2 MD1474 G2 MD 1474G2 MD 990076 A MD990076 A MD 990076A MD 1474 G2 MD1474 G2 MD 1474G2
Authority
MD
Moldova
Prior art keywords
treatment
administration
puerperal endometritis
endometritis
puerperal
Prior art date
Application number
MD99-0076A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1474F1 (en
Inventor
Людмила ЕЦКО
Исаак Гершевич ШРОЙТ
Maria Carlatan
Елена Штефан КАМЫШ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова, Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MD99-0076A priority Critical patent/MD1474G2/en
Publication of MD1474F1 publication Critical patent/MD1474F1/en
Publication of MD1474G2 publication Critical patent/MD1474G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the medicine, in particular to the obstetrics and is used for treatment of puerperal endometritis.The proposed method consists in the administration of a suspension of mononuclear cells culture, obtained from the recipient blood, paracervically on the 3…6 day in the puerperium 1…3 times in a dose of 2 ml in combination with the administration of uterotonic preparations.The result of the invention consists in the immunostimulating action, reduction of the endogenic intoxication and medicamental load on the maternal organism.
MD99-0076A 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis MD1474G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Publications (2)

Publication Number Publication Date
MD1474F1 MD1474F1 (en) 2000-05-31
MD1474G2 true MD1474G2 (en) 2000-12-31

Family

ID=19739343

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0076A MD1474G2 (en) 1999-02-26 1999-02-26 Method of treatment of the puerperal endometritis

Country Status (1)

Country Link
MD (1) MD1474G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (en) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of treatment of the chronic duodenal and recidivating postoperative ulcers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1119G2 (en) * 1998-06-22 1999-07-31 Георге КУШНИР Method for female genitals inflammatory diseases treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1119G2 (en) * 1998-06-22 1999-07-31 Георге КУШНИР Method for female genitals inflammatory diseases treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
КУЛАКОВ, В. И., ЗАК, И. Р., КУЛИКОВА, Н. Н. Послерoдовые инфекционные заболевания. Москва, Медицина, 1984, с. 14-39. *
СТЕПАНКОВСКАЯ, В. К., СОЛЬСКИЙ,Я. П. Послеродовая инфекция. Киев, Здоров’я, 1989, с. 74. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2396G2 (en) * 2003-11-13 2004-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method of treatment of the chronic duodenal and recidivating postoperative ulcers

Also Published As

Publication number Publication date
MD1474F1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
AU3844297A (en) Treatment of autoimmune diseases
HUS1400034I1 (en) Use of dialkylfumarates for producing pharmaceutical compositions for the treatment autoimmune diseases
MY111196A (en) Therapeutic aplication of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
AU3368497A (en) Human dnase i hyperactive variants
GB2357969A (en) Improvements in or relating to the treatment of lesions
CA2229282A1 (en) Use of hyaluronic acid as an immunosuppressant
CA2123049A1 (en) Pharmaceutical containing the p40 subunit of interleukin 12
PL365246A1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
AU7128296A (en) Pharmaceutical combination preparations containing erythropoietin and iron preparations
CA2186423A1 (en) Protein which induces interferon-gamma production by immunocompetent cell
EP1002538A3 (en) Stem cell and lymphocyte storage
EP0363083A3 (en) Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease
Hiki et al. Cytosolic and membrane-bound nitric oxide synthase
MD1474G2 (en) Method of treatment of the puerperal endometritis
MD1475G2 (en) Method of prophylaxis of the puerperal endometritis
MX9803610A (en) Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system.
MD1119G2 (en) Method for female genitals inflammatory diseases treatment
ATE293445T1 (en) PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO-(5.2.1.0(2.6))-DEC-9-YL-XANTHOGENATE AND THEIR USE AS MEDICINAL PRODUCTS
EP0371733A3 (en) Dopamine-beta-hydroxylase inhibitors
UA5743C2 (en) Preparation of biologically active tissue substances possessing regenerative activity and method for its production
WO1992002612A3 (en) Tissue plasminogen activator variants with decreased clearance
EP0811385A3 (en) Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease

Legal Events

Date Code Title Description
PD99 Pending application